Insider · CIK 0002046615
John A. Ballantyne Revocable Living Trust dated 08/01/2017
Files at GCTK (Glucotrack, Inc.). First filing -, latest -.
John A. Ballantyne Revocable Living Trust dated 08/01/2017 files SEC Form 4 as 10% owner at GCTK (Glucotrack, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John A. Ballantyne Revocable Living Trust dated 08/01/2017 has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 14, 2024 | GCTK Glucotrack, Inc. | JOther Common Stock, par value $0.001 per share | +132,036 | $31.00 | $4.1M | 183,039 | Mar 31, 2025 |
| Mar 12, 2025 | GCTK Glucotrack, Inc. | XIn-the-money exercise Common Stock, par value $0.001 per share | +2,560,553 | $0.00 | $0 | 2,743,591 | Mar 31, 2025 |
| Jul 30, 2024 | GCTK Glucotrack, Inc. | POpen-market purchase Warrants to Purchase Common Stockderivative | +106,667 | - | - | 106,667 | Mar 31, 2025 |
| Jul 30, 2024 | GCTK Glucotrack, Inc. | POpen-market purchase Warrants to Purchase Common Stockderivative | +76,191 | - | - | 76,191 | Mar 31, 2025 |
| Jul 30, 2024 | GCTK Glucotrack, Inc. | POpen-market purchase Warrants to Purchase Common Stockderivative | +59,260 | - | - | 59,260 | Mar 31, 2025 |
| Nov 14, 2024 | GCTK Glucotrack, Inc. | AGrant or award Series A Common Warrantderivative | +132,036 | - | - | 132,036 | Mar 31, 2025 |
| Nov 14, 2024 | GCTK Glucotrack, Inc. | AGrant or award Series B Common Warrantderivative | +132,036 | - | - | 132,036 | Mar 31, 2025 |
| Mar 12, 2025 | GCTK Glucotrack, Inc. | XIn-the-money exercise Series B Common Warrantderivative | -132,036 | $0.00 | $0 | 0 | Mar 31, 2025 |
Questions about John A. Ballantyne Revocable Living Trust dated 08/01/2017
Answered from the filings on this page, as of the latest one.
Is John A. Ballantyne Revocable Living Trust dated 08/01/2017 buying or selling?
John A. Ballantyne Revocable Living Trust dated 08/01/2017 has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John A. Ballantyne Revocable Living Trust dated 08/01/2017's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John A. Ballantyne Revocable Living Trust dated 08/01/2017 has 0.
Where does John A. Ballantyne Revocable Living Trust dated 08/01/2017 file Form 4?
John A. Ballantyne Revocable Living Trust dated 08/01/2017 has filed Form 4 at GCTK (Glucotrack, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.